Studies on catecholamines, renin and aldosterone following catapresan® (2-(2,6-dichlor-phenylamine)-2-imidazoline hydrochloride) in hypertensive patients
- 30 June 1970
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 10 (3) , 389-397
- https://doi.org/10.1016/0014-2999(70)90212-8
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- CATECHOLAMINES, RENIN AND ALDOSTERONE IN POSTURAL HYPOTENSIONActa Endocrinologica, 1969
- Mechanisms of the pressor and depressor actions of St 155 (2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, catapres®)European Journal of Pharmacology, 1968
- Centrally mediated decrease in sympathetic tone induced by 2(2,6-dichlorophenylamino)-2 imidazoline (S.T. 155, Catapresan)European Journal of Pharmacology, 1967
- The antihypertensive effects of an imidazoline compoundClinical Pharmacology & Therapeutics, 1967
- Acute hypotensive action of 2-(2,6-dichlorophenylamino)- 2-imidazoline hydrochloride (St 155) after infusion into the cat's vertebral arteryEuropean Journal of Pharmacology, 1967
- Role of the Sympathetic Nervous System in Regulating Renin and Aldosterone Production in Man *Journal of Clinical Investigation, 1967
- IMPROVEMENT IN METHODOLOGY FOR MEASUREMENT OF PLASMA RENIN ACTIVITYCanadian Journal of Physiology and Pharmacology, 1966
- Effect of catecholamines and the renal nerves on renin secretion in anesthetized dogsAmerican Journal of Physiology-Legacy Content, 1965
- Improved Technique for the Fluorimetric Estimation of CatecholaminesActa Physiologica Scandinavica, 1961
- Hypotensive Agents and Pressor SubstancesPublished by American Medical Association (AMA) ,1960